BTIG Maintains Buy on CareDx, Raises Price Target to $45

Benzinga Newsdesk www.benzinga.com Positive 69.5%

Neg 0% Neu 0% Pos 69.5%

BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $28 to $45.

Comments

No comments yet. Be the first!